Template:Spinal Muscular Atrophy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 28: | Line 28: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Spinal Muscular Atrophy | | [[Spinal Muscular Atrophy Epidemiology |epidemiology ]] | ||
|- | |- | ||
! | ! | ||
Line 40: | Line 40: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Spinal Muscular Atrophy | [[Spinal Muscular Atrophy Carrier testing and newborn Screening |carrier testing and newborn Screening]] | ||
|- | |- | ||
! | ! | ||
Line 46: | Line 46: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Spinal Muscular Atrophy | [[Spinal Muscular Atrophy Other forms |other forms]] | ||
|- | |- | ||
! | ! | ||
Line 64: | Line 64: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Spinal Muscular Atrophy | [[Spinal Muscular Atrophy Types |types]] | ||
|- | |- | ||
! | ! | ||
Line 70: | Line 70: | ||
|- bgcolor="CornFlowerBlue" | |- bgcolor="CornFlowerBlue" | ||
! | ! | ||
[[Spinal Muscular Atrophy | | [[Spinal Muscular Atrophy Diagnosis|diagnosis]] | ||
|- | |- | ||
! | ! | ||
Line 76: | Line 76: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Spinal Muscular Atrophy | | [[Spinal Muscular Atrophy Causes|causes]] | ||
|- | |- | ||
! | ! | ||
Line 88: | Line 88: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Spinal Muscular Atrophy | [[Spinal Muscular Atrophy Symptom |symptom]] | ||
|- | |- | ||
! | ! | ||
Line 148: | Line 148: | ||
|- bgcolor="CadetBlue" | |- bgcolor="CadetBlue" | ||
! | ! | ||
[[Spinal Muscular Atrophy | | [[Spinal Muscular Atrophy Treatment|treatment]] | ||
|- | |- | ||
! | ! | ||
Line 154: | Line 154: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Spinal Muscular Atrophy | [[Spinal Muscular Atrophy Outcome measures in SMA |outcome measures in SMA]] | ||
|- | |- | ||
! | ! | ||
Line 160: | Line 160: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Spinal Muscular Atrophy | | [[Spinal Muscular Atrophy Therapeutics development in SMA |therapeutics development in SMA]] | ||
|- | |- | ||
! | ! | ||
Line 172: | Line 172: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Spinal Muscular Atrophy | | [[Spinal Muscular Atrophy Research|research]] | ||
|- | |- | ||
! | ! |
Revision as of 14:47, 24 June 2011
Spinal Muscular Atrophy Microchapters |
Spinal Muscular Atrophy Resources |
---|
Ongoing Trials on Spinal Muscular Atrophy at Clinical Trials.gov |
US National Guidelines Clearinghouse on Spinal Muscular Atrophy |
Risk calculators and risk factors for Spinal Muscular Atrophy |